NRX Pharmaceuticals Inc (NRXP)
Stock chart
Loading...
•
Purchase
•
Sale
•
Planned purchase
•
Planned sale
Net purchase
Net sale
Earnings
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2024-12-18 | 2024-12-17 | B Purchase |
Chairman and Chief Scientist Executive Director Large shareholder |
40,000
+89.6%
1.17USD 46,800 |
40,000 +89.6% | 1.17 | USD 46,800 | |
| 2023-09-11 | 2023-08-30 | B Purchase | Non-Executive Director |
35,000
+50.0%
0.32USD 11,197 |
35,000 +50.0% | 0.32 | USD 11,197 | |
| 2023-09-11 | 2023-08-30 | B Purchase | Non-Executive Director |
70,000
+14.0%
0.29USD 20,125 |
70,000 +14.0% | 0.29 | USD 20,125 | |
| 2023-08-24 | 2023-08-23 | B Purchase |
Chief Scientist Executive Director Large shareholder |
100,000
+28.9%
0.33USD 33,000 |
100,000 +28.9% | 0.33 | USD 33,000 | |
| 2023-08-23 | 2023-08-22 | B Purchase |
Chief Scientist Executive Director Large shareholder |
200,000
+136.7%
0.32USD 64,400 |
200,000 +136.7% | 0.32 | USD 64,400 | |
| 2022-12-19 | 2022-12-16 | B Purchase |
CHIEF EXECUTIVE OFFICER Executive Director |
50,000
+inf%
1.17USD 58,500 |
50,000 +inf% | 1.17 | USD 58,500 | |
| 2022-12-19 | 2022-12-16 | B Purchase |
CHIEF FINANCIAL OFFICER Officer |
30,000
+183.6%
1.10USD 33,000 |
30,000 +183.6% | 1.10 | USD 33,000 | |
| 2022-12-09 | 2022-12-07 | S Sale | Non-Executive Director Large shareholder |
400,000
-3.0%
1.00USD 400,000 |
400,000 -3.0% | 1.00 | USD 400,000 | |
| 2022-12-01 | 2022-11-30 | PS Planned sale | Large shareholder |
8,441
-0.1%
1.50USD 12,700 |
8,441 -0.1% | 1.50 | USD 12,700 | |
| 2022-12-01 | 2022-11-29 | PS Planned sale | Large shareholder |
13,730
-0.1%
1.50USD 20,651 |
13,730 -0.1% | 1.50 | USD 20,651 | |
| 2022-11-29 | 2022-11-28 | B Purchase | Non-Executive Director |
1,750
+inf%
1.25USD 2,188 |
1,750 +inf% | 1.25 | USD 2,188 | |
| 2022-11-29 | 2022-11-28 | B Purchase | Non-Executive Director |
2,500
+6.6%
1.24USD 3,100 |
2,500 +6.6% | 1.24 | USD 3,100 | |
| 2022-11-29 | 2022-11-28 | B Purchase | Non-Executive Director |
2,500
+7.1%
1.25USD 3,125 |
2,500 +7.1% | 1.25 | USD 3,125 | |
| 2022-11-29 | 2022-11-28 | B Purchase | Non-Executive Director |
2,500
+6.6%
1.25USD 3,125 |
2,500 +6.6% | 1.25 | USD 3,125 | |
| 2022-11-29 | 2022-11-28 | B Purchase | Non-Executive Director |
2,500
+7.1%
1.25USD 3,125 |
2,500 +7.1% | 1.25 | USD 3,125 | |
| 2022-11-28 | 2022-11-25 | B Purchase |
CHIEF FINANCIAL OFFICER Officer |
7,021
+75.0%
1.11USD 7,793 |
7,021 +75.0% | 1.11 | USD 7,793 | |
| 2022-11-28 | 2022-11-25 | B Purchase |
CHIEF FINANCIAL OFFICER Officer |
600
+6.9%
1.10USD 660 |
600 +6.9% | 1.10 | USD 660 | |
| 2022-11-28 | 2022-11-25 | B Purchase |
CHIEF FINANCIAL OFFICER Officer |
8,716
+inf%
1.12USD 9,762 |
8,716 +inf% | 1.12 | USD 9,762 | |
| 2022-11-21 | 2022-11-18 | B Purchase | Non-Executive Director |
40,408
+8.8%
1.10USD 44,449 |
40,408 +8.8% | 1.10 | USD 44,449 | |
| 2022-11-21 | 2022-11-17 | B Purchase | Non-Executive Director |
171,780
+59.7%
1.08USD 185,522 |
171,780 +59.7% | 1.08 | USD 185,522 | |
| 2022-11-18 | 2022-11-17 | PS Planned sale | Large shareholder |
33,018
-0.3%
1.05USD 34,745 |
33,018 -0.3% | 1.05 | USD 34,745 | |
| 2022-11-21 | 2022-11-16 | B Purchase | Non-Executive Director |
287,812
+inf%
0.99USD 284,934 |
287,812 +inf% | 0.99 | USD 284,934 | |
| 2022-11-18 | 2022-11-16 | PS Planned sale | Large shareholder |
133,719
-1.4%
1.02USD 136,393 |
133,719 -1.4% | 1.02 | USD 136,393 | |
| 2022-11-15 | 2022-11-11 | PS Planned sale | Large shareholder |
49,200
-0.5%
1.01USD 49,510 |
49,200 -0.5% | 1.01 | USD 49,510 | |
| 2022-08-02 | 2022-07-29 | S Sale | Large shareholder |
784,063
-7.4%
1.01USD 791,433 |
784,063 -7.4% | 1.01 | USD 791,433 | |
| 2022-06-07 | 2022-06-07 | S Sale | Large shareholder |
86,459
-0.7%
0.65USD 55,861 |
86,459 -0.7% | 0.65 | USD 55,861 | |
| 2022-06-07 | 2022-06-06 | S Sale | Large shareholder |
115,657
-0.9%
0.67USD 76,947 |
115,657 -0.9% | 0.67 | USD 76,947 | |
| 2022-06-07 | 2022-06-03 | S Sale | Large shareholder |
243,596
-1.9%
0.70USD 171,102 |
243,596 -1.9% | 0.70 | USD 171,102 | |
| 2022-06-02 | 2022-06-01 | B Purchase |
Chief Scientist Executive Director Large shareholder |
100,000
+215.8%
58.00USD 5,800,000 |
100,000 +215.8% | 58.00 | USD 5,800,000 | |
| 2021-11-02 | 2021-09-15 | S Sale |
Chief Comm. & Patient Officer Officer |
40,000
-62.8%
11.76USD 470,400 |
40,000 -62.8% | 11.76 | USD 470,400 | |
| 2021-11-02 | 2021-08-23 | S Sale |
General Counsel & Secretary Officer |
33,715
-100.0%
13.11USD 442,004 |
33,715 -100.0% | 13.11 | USD 442,004 | |
| 2020-03-17 | 2020-03-13 | S Sale |
Polar Asset Management Partners Inc. Large shareholder |
29,464
-5.7%
10.60USD 312,318 |
29,464 -5.7% | 10.60 | USD 312,318 | |
| 2018-11-20 | 2018-11-20 | S Sale |
ACKERMAN RICHARD President and CEO |
1,500,000
0.00USD 0 |
1,500,000 | 0.00 | USD 0 | |
| 2017-12-04 | 2017-11-29 | B Purchase |
ACKERMAN RICHARD President and CEO |
22,500
+9.0%
10.00USD 225,000 |
22,500 +9.0% | 10.00 | USD 225,000 |